RTN4RL2 | Reticulon 4 receptor-like 2 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SLC30A2 | Solute carrier family 30 (zinc transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC5A8 | Solute carrier family 5 (sodium/monocarboxylate cotransporter), member 8 | Predicted membrane proteins
| | | | | Tissue enriched |
SORD | Sorbitol dehydrogenase | Enzymes Plasma proteins
| | | | | Group enriched |
TDRD9 | Tudor domain containing 9 | Enzymes
| | | | | Group enriched |
TMEM132B | Transmembrane protein 132B | Predicted membrane proteins
| | | | | Group enriched |
TNFRSF11B | Tumor necrosis factor receptor superfamily, member 11b | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
ZMAT4 | Zinc finger, matrin-type 4 | | | | | | Tissue enriched |
ARG2 | Arginase 2 | Cancer-related genes Enzymes Mitochondrial proteins
| | | | | Group enriched |
BTBD11 | BTB (POZ) domain containing 11 | | | | | | Group enriched |
CLIC3 | Chloride intracellular channel 3 | Plasma proteins Transporters
| | | | | Group enriched |
CORO6 | Coronin 6 | | | | | | Group enriched |
TEKT4 | Tektin 4 | | | | | | Group enriched |
ADM2 | Adrenomedullin 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
AFAP1L2 | Actin filament associated protein 1-like 2 | | | | | | Tissue enhanced |
AL589739.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AP001350.1 | Uncharacterized protein | | | | | | Tissue enhanced |
ATP13A4 | ATPase type 13A4 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
BMP7 | Bone morphogenetic protein 7 | Predicted secreted proteins
| | | | | Tissue enhanced |
BMP8B | Bone morphogenetic protein 8b | Predicted secreted proteins
| | | | | Tissue enhanced |
C16orf89 | Chromosome 16 open reading frame 89 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C3orf55 | Chromosome 3 open reading frame 55 | Predicted membrane proteins
| | | | | Tissue enhanced |
CDON | Cell adhesion associated, oncogene regulated | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CNTN5 | Contactin 5 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CNTN6 | Contactin 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
COL23A1 | Collagen, type XXIII, alpha 1 | | | | | | Tissue enhanced |
COL8A1 | Collagen, type VIII, alpha 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COL9A3 | Collagen, type IX, alpha 3 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CRABP1 | Cellular retinoic acid binding protein 1 | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
DCDC2 | Doublecortin domain containing 2 | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
DGKI | Diacylglycerol kinase, iota | Enzymes
| | | | | Tissue enhanced |
DIO2 | Deiodinase, iodothyronine, type II | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DMRT3 | Doublesex and mab-3 related transcription factor 3 | Transcription factors
| | | | | Tissue enhanced |
DOCK3 | Dedicator of cytokinesis 3 | Disease related genes
| | | | | Tissue enhanced |
DUOX1 | Dual oxidase 1 | Enzymes Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
DUOXA1 | Dual oxidase maturation factor 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
EGR2 | Early growth response 2 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
ENPP5 | Ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative) | Predicted membrane proteins
| | | | | Tissue enhanced |
ESM1 | Endothelial cell-specific molecule 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
ESYT3 | Extended synaptotagmin-like protein 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
FAM150A | Family with sequence similarity 150, member A | Predicted secreted proteins
| | | | | Tissue enhanced |
FAM167A | Family with sequence similarity 167, member A | | | | | | Tissue enhanced |
FAM189A2 | Family with sequence similarity 189, member A2 | Predicted membrane proteins
| | | | | Tissue enhanced |
FNDC1 | Fibronectin type III domain containing 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
FRAS1 | Fraser syndrome 1 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FREM2 | FRAS1 related extracellular matrix protein 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
FRMPD3 | FERM and PDZ domain containing 3 | Cytoskeleton related proteins
| | | | | Tissue enhanced |
GAL3ST3 | Galactose-3-O-sulfotransferase 3 | Predicted secreted proteins
| | | | | Tissue enhanced |
GLIS3 | GLIS family zinc finger 3 | Disease related genes Predicted secreted proteins Transcription factors
| | | | | Tissue enhanced |
GOLGA8M | Golgin A8 family, member M | | | | | | Tissue enhanced |